EN
詢價車

化學材料

MIL-101(Al)-NH2 比表面積~800m2/g

MIL-101(Al)-NH2 比表面積~800m2/g

T281776-1G / 1G
CAS：1404201-64-4
加入洽詢
MIL-101(Al)-NH2 比表面積~800m2/g

MIL-101(Al)-NH2 比表面積~800m2/g

T281776-500MG / 500MG
CAS：1404201-64-4
加入洽詢
2,2,4,4-Tetramethyl-3,8,11,14,17-pentaoxa-2,4-disilaoctadecane ≥98% Electrolyte solvent ANL-2SM3

2,2,4,4-Tetramethyl-3,8,11,14,17-pentaoxa-2,4-disilaoctadecane ≥98% Electrolyte solvent ANL-2SM3

T281788-25G / 25G
CAS：855996-83-7
加入洽詢
2,2,4,4-Tetramethyl-3,8,11,14,17-pentaoxa-2,4-disilaoctadecane ≥98% Electrolyte solvent ANL-2SM3

2,2,4,4-Tetramethyl-3,8,11,14,17-pentaoxa-2,4-disilaoctadecane ≥98% Electrolyte solvent ANL-2SM3

T281788-5G / 5G
CAS：855996-83-7
加入洽詢
Tri-t-pentoxysilanol PrimorTrace™, ≥99.999% metals basis

Tri-t-pentoxysilanol PrimorTrace™, ≥99.999% metals basis

T281796-1G / 1G
CAS：17906-35-3
加入洽詢
Tri-t-pentoxysilanol PrimorTrace™, ≥99.999% metals basis

Tri-t-pentoxysilanol PrimorTrace™, ≥99.999% metals basis

T281796-25G / 25G
CAS：17906-35-3
加入洽詢
Tri-t-pentoxysilanol PrimorTrace™, ≥99.999% metals basis

Tri-t-pentoxysilanol PrimorTrace™, ≥99.999% metals basis

T281796-5G / 5G
CAS：17906-35-3
加入洽詢
Tris(trimethylsilyl)methane ≥97%

Tris(trimethylsilyl)methane ≥97%

T281801-1G / 1G
CAS：1068-69-5
加入洽詢
Tris(trimethylsilyl)methane ≥97%

Tris(trimethylsilyl)methane ≥97%

T281801-5G / 5G
CAS：1068-69-5
加入洽詢
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,≥99%(ee)

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,≥99%(ee)

T281864-100MG / 100MG
CAS：1297613-73-0
加入洽詢
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,≥99%(ee)

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,≥99%(ee)

T281864-50MG / 50MG
CAS：1297613-73-0
加入洽詢
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1'',7''-fg][1,3,2]dioxaphosphocin ≥98%,≥99%(ee)

(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1'',7''-fg][1,3,2]dioxaphosphocin ≥98%,≥99%(ee)

T281894-50MG / 50MG
CAS：1258276-28-6
加入洽詢
Tetramethyl 6,6''-bis(diphenylphosphino)-1,1'',3,3''-tetrahydro[5,5'']biindenyl-2,2'',2,2''-tetracarboxylate ≥99%

Tetramethyl 6,6''-bis(diphenylphosphino)-1,1'',3,3''-tetrahydro[5,5'']biindenyl-2,2'',2,2''-tetracarboxylate ≥99%

T281909-100MG / 100MG
CAS：959864-39-2
加入洽詢
Tetramethyl 6,6''-bis(diphenylphosphino)-1,1'',3,3''-tetrahydro[5,5'']biindenyl-2,2'',2,2''-tetracarboxylate ≥99%

Tetramethyl 6,6''-bis(diphenylphosphino)-1,1'',3,3''-tetrahydro[5,5'']biindenyl-2,2'',2,2''-tetracarboxylate ≥99%

T281909-500MG / 500MG
CAS：959864-39-2
加入洽詢
(11aS)-1,2,10,11-Tetramethyl-4,8-bis(t-butyl)-6-[[(2S,5S)-(2,5-diphenyl-1-phospholanyl) methoxy]-dibenzo[d,f][1,3,2]dioxaphosphepin] SaxS,S-BOBPHOS ≥95%

(11aS)-1,2,10,11-Tetramethyl-4,8-bis(t-butyl)-6-[[(2S,5S)-(2,5-diphenyl-1-phospholanyl) methoxy]-dibenzo[d,f][1,3,2]dioxaphosphepin] SaxS,S-BOBPHOS ≥95%

T281923-100MG / 100MG
CAS：1373349-83-7
加入洽詢
(11aS)-1,2,10,11-Tetramethyl-4,8-bis(t-butyl)-6-[[(2S,5S)-(2,5-diphenyl-1-phospholanyl) methoxy]-dibenzo[d,f][1,3,2]dioxaphosphepin] SaxS,S-BOBPHOS ≥95%

(11aS)-1,2,10,11-Tetramethyl-4,8-bis(t-butyl)-6-[[(2S,5S)-(2,5-diphenyl-1-phospholanyl) methoxy]-dibenzo[d,f][1,3,2]dioxaphosphepin] SaxS,S-BOBPHOS ≥95%

T281923-500MG / 500MG
CAS：1373349-83-7
加入洽詢
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1'',7''-fg][1,3,2]dioxaphosphocin ≥98%,≥99%(ee)

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1'',7''-fg][1,3,2]dioxaphosphocin ≥98%,≥99%(ee)

T281930-10MG / 10MG
CAS：1372719-95-3
加入洽詢
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1'',7''-fg][1,3,2]dioxaphosphocin ≥98%,≥99%(ee)

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1'',7''-fg][1,3,2]dioxaphosphocin ≥98%,≥99%(ee)

T281930-50MG / 50MG
CAS：1372719-95-3
加入洽詢
Tri-i-butyl(methyl)phosphonium tosylate ≥95%

Tri-i-butyl(methyl)phosphonium tosylate ≥95%

T281998-25G / 25G
CAS：374683-35-9
加入洽詢
Tri-i-butyl(methyl)phosphonium tosylate ≥95%

Tri-i-butyl(methyl)phosphonium tosylate ≥95%

T281998-5G / 5G
CAS：374683-35-9
加入洽詢
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1'',7''-fg][1,3,2]dioxaphosphocin ≥97%

(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1'',7''-fg][1,3,2]dioxaphosphocin ≥97%

T282002-100MG / 100MG
CAS：1585988-92-6
加入洽詢
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1'',7''-fg][1,3,2]dioxaphosphocin ≥97%

(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1'',7''-fg][1,3,2]dioxaphosphocin ≥97%

T282002-25MG / 25MG
CAS：1585988-92-6
加入洽詢
(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-dimethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥97%

(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-dimethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥97%

T282023-100MG / 100MG
CAS：1019840-96-0
加入洽詢
(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-dimethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥97%

(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-dimethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥97%

T282023-1G / 1G
CAS：1019840-96-0
加入洽詢
(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-dimethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥97%

(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-dimethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥97%

T282023-250MG / 250MG
CAS：1019840-96-0
加入洽詢
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-dimethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin ≥95%,≥99%(ee)

(3aS,8aS)-4,4,8,8-Tetrakis(3,5-dimethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin ≥95%,≥99%(ee)

T282024-100MG / 100MG
CAS：1169835-86-2
加入洽詢
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-dimethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin ≥95%,≥99%(ee)

(3aS,8aS)-4,4,8,8-Tetrakis(3,5-dimethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin ≥95%,≥99%(ee)

T282024-1G / 1G
CAS：1169835-86-2
加入洽詢
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-dimethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin ≥95%,≥99%(ee)

(3aS,8aS)-4,4,8,8-Tetrakis(3,5-dimethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin ≥95%,≥99%(ee)

T282024-500MG / 500MG
CAS：1169835-86-2
加入洽詢
(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-di-i-propylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥97%,≥99%(ee)

(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-di-i-propylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥97%,≥99%(ee)

T282025-100MG / 100MG
CAS：1361146-90-8
加入洽詢
(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-di-i-propylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥97%,≥99%(ee)

(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-di-i-propylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥97%,≥99%(ee)

T282025-1G / 1G
CAS：1361146-90-8
加入洽詢
(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-di-i-propylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥97%,≥99%(ee)

(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-di-i-propylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥97%,≥99%(ee)

T282025-250MG / 250MG
CAS：1361146-90-8
加入洽詢
(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-di-i-propylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥97%,≥99%(ee)

(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-di-i-propylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥97%,≥99%(ee)

T282025-500MG / 500MG
CAS：1361146-90-8
加入洽詢
(3aS,8aS)-(+)-4,4,8,8-Tetrakis(3,5-di-i-propylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥95%

(3aS,8aS)-(+)-4,4,8,8-Tetrakis(3,5-di-i-propylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥95%

T282026-100MG / 100MG
CAS：1422371-27-4
加入洽詢
(3aS,8aS)-(+)-4,4,8,8-Tetrakis(3,5-di-i-propylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥95%

(3aS,8aS)-(+)-4,4,8,8-Tetrakis(3,5-di-i-propylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥95%

T282026-1G / 1G
CAS：1422371-27-4
加入洽詢
(3aS,8aS)-(+)-4,4,8,8-Tetrakis(3,5-di-i-propylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥95%

(3aS,8aS)-(+)-4,4,8,8-Tetrakis(3,5-di-i-propylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥95%

T282026-500MG / 500MG
CAS：1422371-27-4
加入洽詢
(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-diethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥95%

(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-diethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥95%

T282027-100MG / 100MG
CAS：1187446-93-0
加入洽詢
(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-diethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥95%

(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-diethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin ≥95%

T282027-500MG / 500MG
CAS：1187446-93-0
加入洽詢
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1'',7''-fg] [1,3,2]dioxaphosphocin ≥98%,≥99%(ee)

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1'',7''-fg] [1,3,2]dioxaphosphocin ≥98%,≥99%(ee)

T282063-50MG / 50MG
CAS：1297613-72-9
加入洽詢
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1'',7''-fg] [1,3,2]dioxaphosphocin ≥98%,≥99%(ee)

(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1'',7''-fg] [1,3,2]dioxaphosphocin ≥98%,≥99%(ee)

T282064-50MG / 50MG
CAS：1258327-04-6
加入洽詢
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1'',7''-fg] [1,3,2]dioxaphosphocin 98%,(99% ee) ≥98%,≥99%(ee)

(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1'',7''-fg] [1,3,2]dioxaphosphocin 98%,(99% ee) ≥98%,≥99%(ee)

T282065-50MG / 50MG
CAS：1258327-08-0
加入洽詢
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,≥99%(ee)

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,≥99%(ee)

T282066-10MG / 10MG
CAS：1297613-74-1
加入洽詢
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,≥99%(ee)

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,≥99%(ee)

T282066-50MG / 50MG
CAS：1297613-74-1
加入洽詢
2-(t-Butylphenylphosphino)-2',6'-dimethylamino-1,1'-biphenyl ≥98%

2-(t-Butylphenylphosphino)-2',6'-dimethylamino-1,1'-biphenyl ≥98%

T282084-1G / 1G
CAS：1660153-91-2
加入洽詢
2-(t-Butylphenylphosphino)-2',6'-dimethylamino-1,1'-biphenyl ≥98%

2-(t-Butylphenylphosphino)-2',6'-dimethylamino-1,1'-biphenyl ≥98%

T282084-250MG / 250MG
CAS：1660153-91-2
加入洽詢
2-(t-Butylphenylphosphino)-2',6'-dimethylamino-1,1'-biphenyl ≥98%

2-(t-Butylphenylphosphino)-2',6'-dimethylamino-1,1'-biphenyl ≥98%

T282084-25G / 25G
CAS：1660153-91-2
加入洽詢
2-(t-Butylphenylphosphino)-2',6'-dimethylamino-1,1'-biphenyl ≥98%

2-(t-Butylphenylphosphino)-2',6'-dimethylamino-1,1'-biphenyl ≥98%

T282084-5G / 5G
CAS：1660153-91-2
加入洽詢
(3-(Tert-butoxy)-2'',6''-diisopropyl-6-methoxy-[1,1''-biphenyl]-2-yl)dicyclohexylphosphane GPhos ≥98%

(3-(Tert-butoxy)-2'',6''-diisopropyl-6-methoxy-[1,1''-biphenyl]-2-yl)dicyclohexylphosphane GPhos ≥98%

T282087-250MG / 250MG
CAS：2489243-29-8
加入洽詢
(3-(Tert-butoxy)-2'',6''-diisopropyl-6-methoxy-[1,1''-biphenyl]-2-yl)dicyclohexylphosphane GPhos ≥98%

(3-(Tert-butoxy)-2'',6''-diisopropyl-6-methoxy-[1,1''-biphenyl]-2-yl)dicyclohexylphosphane GPhos ≥98%

T282087-50MG / 50MG
CAS：2489243-29-8
加入洽詢
(11aS)-5-tert-Butyl-10,11,12,13-tetrahydro-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥97%

(11aS)-5-tert-Butyl-10,11,12,13-tetrahydro-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥97%

T282102-100MG / 100MG
CAS：912457-08-0
加入洽詢
(11aS)-5-tert-Butyl-10,11,12,13-tetrahydro-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥97%

(11aS)-5-tert-Butyl-10,11,12,13-tetrahydro-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥97%

T282102-25MG / 25MG
CAS：912457-08-0
加入洽詢
LOCATIONS

服務據點

北北基/宜蘭/花蓮
  • 北北基/宜蘭/花蓮
  • 桃園
  • 新竹縣/新竹市/苗栗
  • 台中/彰化/南投
  • 雲林/嘉義/台南
  • 高雄/屏東/台東

台北分公司

地址 台北市南港區南港路三段50巷10號5樓
電話 02-2786-2331
傳真 02-2653-6959
郵件 taipei@echochemical.com

桃園分公司

地址 桃園市平鎮區復興街62號2樓
電話 03-494-6939
傳真 03-493-0687
郵件 chungli@echochemical.com

總公司 / 竹苗分公司

地址 苗栗縣頭份市工業路16號
電話 037-621-088
傳真 037-615-096
郵件 miaoli@echochemical.com

台中分公司

地址 台中市南屯區文心路一段218號15F之2
電話 04-2472-8859
傳真 04-2472-8825
郵件 taichung@echochemical.com

台南分公司

地址 台南市永康區鹽洲一街63巷33號
電話 06-243-6589
傳真 06-253-8208
郵件 tainan@echochemical.com

高雄分公司

地址 高雄市鳳山區鳳頂路479號
電話 07-753-9988
傳真 07-753-1958
郵件 kaohsiung@echochemical.com
北北基/宜蘭/花蓮 桃園 新竹縣/新竹市/苗栗 台中/彰化/南投 雲林/嘉義/台南 高雄/屏東/台東
mapNorth
mapTaoyuan
mapHsinchu
mapCentral
mapYunlin
mapSouth
EN
詢價車
洽詢車

你的洽詢車總計 0 件產品

洽詢表單
依據歐盟施行的個人資料保護法，我們致力於保護您的個人資料並提供您對個人資料的掌握。
按一下「全部接受」，代表您允許我們置放 Cookie 來提升您在本網站上的使用體驗、協助我們分析網站效能和使用狀況，以及讓我們投放相關聯的行銷內容。您可以在下方管理 Cookie 設定。 按一下「確認」即代表您同意採用目前的設定。
管理Cookies

隱私權偏好設定中心

依據歐盟施行的個人資料保護法，我們致力於保護您的個人資料並提供您對個人資料的掌握。
按一下「全部接受」，代表您允許我們置放 Cookie 來提升您在本網站上的使用體驗、協助我們分析網站效能和使用狀況，以及讓我們投放相關聯的行銷內容。您可以在下方管理 Cookie 設定。 按一下「確認」即代表您同意採用目前的設定。
查看隱私權政策

管理同意設定

必要的Cookie

一律啟用
網站運行離不開這些 Cookie 且您不能在系統中將其關閉。通常僅根據您所做出的操作（即服務請求）來設置這些 Cookie，如設置隱私偏好、登錄或填充表格。您可以將您的瀏覽器設置為阻止或向您提示這些 Cookie，但可能會導致某些網站功能無法工作。